BD announces fourth quarter and full year fiscal 2026 financial results
Management hosts an audio webcast on November 5, 2026, to discuss the Q4 and full-year fiscal 2026 results ending September 30, alongside operational updates.
See the latest news and media coverage for BD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical technology company
bd.comLast updated
In short: BD announced a $19 billion U.S. manufacturing investment and a $1 billion Nebraska investment.
Management hosts an audio webcast on November 5, 2026, to discuss the Q4 and full-year fiscal 2026 results ending September 30, alongside operational updates.
The company plans a $19 billion investment, increasing domestic supply of essential medical consumables to 80%, and gains tariff relief under Section 232.
Revenue increased 5.4% to $5.0 billion, driven by strong performance across Medical Essentials and Interventional segments.
Revenue reaches $4.7 billion, up 5.2% reported. Adjusted EPS is $2.90. Raises full-year adjusted EPS guidance. Executes $2.0 billion share repurchase.
BD plans a $19B U.S. investment, including $3B for manufacturing, to boost domestic medical...
Through its pledge, BD will invest $19 billion in the U.S. over the span of "several years," with the outlay taking the form of capital...
BD reported a strong third quarter, saying its first full quarter as the “New BD” exceeded expectations. The company raised its full-year guidance citing momentum...
BD says it recalled the products after reports of users having difficulty removing the obturator (stylet) after placement of the needle set...
Track BD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BD and other trending companies.